An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Süssmuth, Sigurd D., Haider, Salman, Landwehrmeyer, G. Bernhard, Farmer, Ruth, Frost, Chris, Tripepi, Giovanna, Andersen, Claus A., Di Bacco, Marco, Lamanna, Claudia, Diodato, Enrica, Massai, Luisa, DVolume:
79
Language:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.12512
Date:
March, 2015
File:
PDF, 993 KB
english, 2015